Abstract
The US critical care patient monitoring market, which comprises vital signs,
hemodynamic, neurological, and neonatal electroencephalography (EEG)
monitoring, declined very modestly from 2007 to 2008, mainly resulting from
deferred capital equipment purchases in hospitals across the country.
|